Titlebook: Cardiac Drug Therapy; M. Gabriel Khan Book 2015Latest edition Springer Science+Business Media New York 2015 ACE Inhibitor.Antiplatelet.Bet

刪除

Beta-Blocker Controversies,A meta-analysis (Lindholm et al. 2005) concluded that beta-blockers should not remain the first choice in the treatment of primary hypertension. Unfortunately, this analysis included randomized controlled trials (RCTs) with poor methodology.

火車車輪

殺人

narcotic

Hypertension Controversies,This statement is printed on the front cover of The Lancet of October 29, 2005. It is surprising that this peer-reviewed journal would print such a misleading statement.

Clumsy

Myocardial Infarction,Acute coronary syndrome [ACS?=?ST-segment elevation myocardial infarction (STEMI) or non-ST-elevation myocardial infarction (NSTEMI) and unstable angina] is a life-threatening condition (see Fig. 11-1).

iodides

Heart Failure,The world faces an epidemic of heart failure (HF). The plague of HF is common in developed and in developing countries.

Orthodontics

離開

神刊

Antiplatelet Agents, Anticoagulants, Factor Xa Inhibitors, and Thrombin Inhibitors,Antiplatelet agents are used in virtually all patients with coronary heart disease (CHD). Aspirin, the pioneer hallmark agent, is of proven value for the management of:

airborne